Mariko Gordon Sells Stake in Digital Imaging Company

Guru invests in shares in financial services company

Author's Avatar
May 22, 2016
Article's Main Image

Mariko Gordon (Trades, Portfolio) of Daruma Capital Management made her reputation by building her firm from the ground up to more than $2 billion, but her most noteworthy first-quarter transaction involved the sale of a stake in her portfolio.

Gordon sold her 1,151,149-share stake in Electronics for Imaging Inc. (EFII, Financial), a digital imaging company based in Fremont, California, for an average price of $40.82 per share. The divestiture had an impact of -3.22% of Gordon’s portfolio.

Ron Baron (Trades, Portfolio) is Electronics for Imaging’s leading shareholder among the gurus with a stake of 1,250,000 shares. The stake is 2.65% of Electronics for Imaging’s outstanding shares and 0.28% of Baron’s total assets.

Electronics for Imaging has a P/E of 67, a forward P/E of 14.7, a P/B of 2.4 and a P/S of 2.2. GuruFocus gives Electronics for Imaging a Financial Strength rating of 7/10 and a Profitability and Growth rating of 6/10.

02May2017163850.png

Electronics for Imaging sold for $42.23 per share Friday. The DCF Calculator gives Electronics for Imaging a fair value of $6.64.

Gordon invested in a 1,039,502-share stake in EverBank Financial Corp. (EVER, Financial), a banking and financial services company based in Jacksonville, Florida, for an average price of $13.91 per share. The transaction had a 0.98% impact on Gordon’s portfolio.

The stake is 0.83% of EverBank’s outstanding shares and 0.98% of Gordon’s total assets. EverBank’s leading shareholder among the gurus is Jim Simons (Trades, Portfolio) with a stake of 1,385,100 shares. The stake is 1.11% of EverBank’s outstanding shares and 0.04% of Simons’ total assets.

EverBank has a P/E of 13.8, a forward P/E of 9.8, a P/B of 1.1 and a P/S of 2. GuruFocus gives EverBank a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10.

02May2017163851.png

EverBank sold for $14.63 per share Friday. The DCF Calculator gives EverBank a fair value of $11.34.

Gordon trimmed her stake in Briggs & Stratton Corp. (BGG, Financial), a Wauwatosa, Wisconsin-based developer and manufacturer of internal combustion gas engines, by 25%, selling 750,846 shares for an average price of $20.49 per share. The deal had a -0.78% impact on Gordon’s portfolio.

The remaining stake of 2,253,084 shares is 5.2% of Briggs & Stratton’s outstanding shares and 3.37% of Gordon’s total assets. Briggs & Stratton’s leading shareholder among the gurus is Charles Brandes (Trades, Portfolio) with a stake of 2,807,569 shares. The stake is 6.48% of Briggs & Stratton’s outstanding shares and 0.96% of Brandes’ total assets.

Briggs & Stratton has a P/E of 22.6, a forward P/E of 12.8, a P/B of 1.7 and a P/S of 0.5. GuruFocus gives Briggs & Stratton a Financial Strength rating of 7/10 and a Profitability and Growth rating of 6/10.

02May2017163851.png

Briggs & Stratton sold for $21.27 per share Friday. The DCF Calculator gives Briggs & Stratton a fair value of $10.06.

Gordon sold more than 14% of her stake in Babcock & Wilcox Enterprises Inc. (BW, Financial), a Charlotte, North Carolina-based energy generation company. Gordon sold 451,585 shares for an average price of $19.93 per share. The transaction had a -0.56% impact on Gordon’s portfolio.

The remaining stake of 2,496,818 shares is 4.93% of Babcock & Wilcox’s outstanding shares and 3.34% of Gordon’s total assets. Gordon is Babcock & Wilcox’s leading shareholder among the gurus.

Babcock & Wilcox has a P/E of 69.3, a forward P/E of 12.6, a P/B of 1.4 and a P/S of 0.7. GuruFocus gives Babcock & Wilcox a Financial Strength rating of 5/10 and a Profitability and Growth rating of 3/10.

02May2017163851.png

Babcock & Wilcox sold for $21.5 per share Friday. The DCF Calculator gives Babcock & Wilcox a fair value of $3.1.

Gordon hiked her stake in CoStar Group Inc. (CSGP, Financial), a commercial real estate information provider based in Washington, by more than 18% with the purchase of 46,952 shares for an average price of $177.25 per share. The deal had a 0.55% impact on Gordon’s portfolio.

The stake, now 301,006 shares, is 0.92% of CoStar Group’s outstanding shares and 3.54% of Gordon’s total assets. Baron is CoStar’s leading shareholder among the gurus with a stake of 2,927,419 shares. The stake is 8.99% of CoStar’s outstanding shares and 2.91% of Baron’s total assets.

CoStar has a P/E of 329.4, a forward P/E of 43.1, a P/B of 4.1 and a P/S of 8.4. GuruFocus gives CoStar a Financial Strength rating of 9/10 and a Profitability and Growth rating of 7/10.

02May2017163852.png

CoStar Group sold for $197.64 per share Friday. The DCF Calculator gives CoStar Group a fair value of $6.42.

Gordon boosted her stake in Rogers Corp. (ROG, Financial), a maker of specialty materials based in Rogers, Connecticut, by more than 14% with the acquisition of 116,438 shares for an average price of $50.21 per share. The transaction had a 0.44% impact on Gordon’s portfolio.

The stake, now 940,084 shares, is 5.22% of Rogers’ outstanding shares and 3.52% of Gordon’s total assets. Gordon is Rogers’ leading shareholder among the gurus.

Rogers has a P/E of 24.3, a P/B of 1.8 and a P/S of 1.8. GuruFocus gives Rogers a Financial Strength rating of 8/10 and a Profitability and Growth rating of 7/10.

02May2017163853.png

Rogers sold for $62.45 per share Friday. The DCF Calculator gives Rogers a fair value of $27.5.

Gordon increased her stake in Insulet Corp. (PODD, Financial), a medical device company based in Billerica, Massachusetts, by nearly 13%. Gordon purchased 166,639 shares for an average price of $31.44 per share. The deal had a 0.35% impact on Gordon’s portfolio.

The stake, now 1,483,179 shares, is 2.59% of Insulet’s outstanding shares and 3.08% of Gordon’s total assets. Insulet’s leading shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with a stake of 5,194,369 shares. The stake is 9.09% of Insulet’s outstanding shares and 0.18% of PRIMECAP’s total assets.

Insulet has a P/B of 61.8 and a P/S of 4.7. GuruFocus gives Insulet a Financial Strength rating of 6/10 and a Profitability and Growth rating of 4/10.

02May2017163853.png

Insulet sold for $28.56 per share Friday. The DCF Calculator gives Insulet a fair value of $-13.59.

Gordon raised her stake in MasTec Inc. (MTZ, Financial), a Coral Gables, Florida-based company engaged in engineering and construction, by almost 10% with her purchase of 257,060 shares for an average price of $16.3 per share. The transaction had a 0.33% impact on Gordon’s portfolio.

The stake, now 2,872,171 shares, is 3.49% of MasTec’s outstanding shares and 3.64% of Gordon’s total assets. Gordon is MasTec’s leading shareholder among the gurus.

MasTec has a forward P/E of 13, a P/B of 2 and a P/S of 0.4. GuruFocus gives MasTec a Financial Strength rating of 7/10 and a Profitability and Growth rating of 6/10.

02May2017163853.png

MasTec sold for $22.29 per share Friday. The DCF Calculator gives MasTec a fair value of $-10.17.

Start a free seven-day trial of Premium Membership to GuruFocus.